Cargando…

CLL kinetics in the tumor microenvironment

Detalles Bibliográficos
Autores principales:	Sun, Clare, Wiestner, Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689558/ https://www.ncbi.nlm.nih.gov/pubmed/29156668 http://dx.doi.org/10.18632/oncotarget.21467

Ejemplares similares

Validating genomic tools for precision medicine in CLL: ERIC leads the way
por: Wiestner, Adrian
Publicado: (2021)

Harnessing the Effects of BTKi on T Cells for Effective Immunotherapy against CLL
por: Mhibik, Maissa, et al.
Publicado: (2019)

CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL
por: Bryer, Emily, et al.
Publicado: (2022)

Poster: CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL
por: Bryer, Emily, et al.
Publicado: (2022)

Pathogenesis of CLL: the view from the lymph node
por: Wiestner, Adrian
Publicado: (2018)

Booster and Btki Interruption Improve Response to Sars-Cov-2 Vaccine in Patients with CLL
por: Bryer, Emily, et al.
Publicado: (2022)

Humoral and Cellular Immunogenicity of COVID-19 Vaccinations in Patients with CLL
por: Sun, Clare, et al.
Publicado: (2021)

Tumor suppressors revival in CLL
por: Carrà, Giovanna, et al.
Publicado: (2017)

Novel Agents and Emerging Strategies for Targeting the B-Cell Receptor Pathway in CLL
por: Efremov, Dimitar G., et al.
Publicado: (2012)

Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL
por: Collins, McKensie A., et al.
Publicado: (2022)

NF-kB and the CLL microenvironment
por: O’Donnell, Alice, et al.
Publicado: (2023)

Beyond SARS-CoV2, the role of viruses in the pathogenesis of hematologic malignancies
por: Wiestner, Adrian
Publicado: (2022)

BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL
por: Pleyer, Christopher, et al.
Publicado: (2022)

Microvesicles in CLL: predictor of disease progression/relapse
por: Maiti, Guru P., et al.
Publicado: (2017)

Targeted therapy in CLL: changing the treatment paradigm
por: Schneider, Christof, et al.
Publicado: (2019)

Rapid transitions in the standard of care for chronic lymphocytic leukemia (CLL)
por: Seymour, Erlene K.
Publicado: (2019)

Targeting HIF-1α Regulatory Pathways as a Strategy to Hamper Tumor-Microenvironment Interactions in CLL
por: Vitale, Candida, et al.
Publicado: (2021)

Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL
por: Bruch, Peter‐Martin, et al.
Publicado: (2022)

Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting
por: Mhibik, Maissa, et al.
Publicado: (2023)

Tumor Microenvironment and Metabolism
por: Yang, Li V.
Publicado: (2017)

The Tumor Microenvironment and Cancer
por: Chen, Zhen, et al.
Publicado: (2014)

Inflammation in the Tumor Microenvironment
por: Lin, Qing, et al.
Publicado: (2018)

Acidosis Sensing Receptor GPR65 Correlates with Anti-Apoptotic Bcl-2 Family Member Expression in CLL Cells: Potential Implications for the CLL Microenvironment
por: Rosko, Ashley E, et al.
Publicado: (2014)

COVID-19 vaccines for patients with haematological conditions
por: Sun, Clare, et al.
Publicado: (2021)

Direct in vivo Evidence for Increased Proliferation of CLL Cells in Lymph Nodes Compared to Bone Marrow and Peripheral Blood
por: Herndon, Thomas M., et al.
Publicado: (2017)

The Tumor Microenvironment of Pancreatic Cancer
por: Karamitopoulou, Eva
Publicado: (2020)

Role of the Microenvironment in Gastrointestinal Tumors
por: Weygant, Nathaniel, et al.
Publicado: (2019)

Tumor Progression, Microenvironments, and Therapeutics
por: Cheng, Hung-Chi, et al.
Publicado: (2022)

Macrophages in the Glioblastoma Tumor Microenvironment
por: Coniglio, Salvatore J.
Publicado: (2023)

CUDC‐907 blocks multiple pro‐survival signals and abrogates microenvironment protection in CLL
por: Chen, Yixiang, et al.
Publicado: (2018)

RAGE at Tumor Microenvironment. Looking at Tumor-associated Macrophages
por: DELGADO-LÓPEZ, Fernando, et al.
Publicado: (2015)

A community affair in the tumor microenvironment
por: Rodvold, Jeffrey J., et al.
Publicado: (2017)

Targeting hyaluronan accumulation in the tumor microenvironment
por: Li, Xiaoming, et al.
Publicado: (2018)

Hedgehog Signaling in Organogenesis and the Tumor Microenvironment
por: Shimo, Tsuyoshi
Publicado: (2020)

Understanding metabolic reprogramming in tumor microenvironment
por: Shu, Shaokun, et al.
Publicado: (2022)

Is miR-29 an oncogene or tumor suppressor in CLL?
por: Pekarsky, Yuri, et al.
Publicado: (2010)

CLL-033 Is COVID-19 Infection a Trigger for Progression of CLL?
por: Popov, Viola, et al.
Publicado: (2022)

Interplay between Tumor Microenvironment and Cancer Cells
por: Jayappa, Kallesh D., et al.
Publicado: (2016)

Characteristics of Immunobiology in the Tumor Microenvironment- Development of Immunotherapies
por: Song, Jian, et al.
Publicado: (2019)

What Is the Fuss about Integrins and the Tumor Microenvironment?
por: Eble, Johannes A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e46rbsfflm3gd2gimg6gcfidla